PHYTOMEDICINE 润色咨询

PHYTOMEDICINE

出版年份:1994 年文章数:2603 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-04-22 ms8000001456519294 来自北京

    审稿速度:3.0 | 投稿命中率:5.0
    偏重的研究方向:中药药理
    经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-03-06 ms3000001245664520 来自四川省

    偏重的研究方向:中药单体;单体
    经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。

    8

    展开8条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-04-10 Dr123 来自广东省

    偏重的研究方向:代谢组学;中药复方;作用机制
    经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。

    15

    展开15条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-04-12 雨念 来自浙江省

    求助under editor assessment需要多久呀

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2023-01-04 ms5000001894093922 来自北京

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:中药单体;药理机制
    经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:
    * 11.08 submit
    * 11.11 改格式
    * 11.14 under editor assessment
    * 11.15 reviewer invited + under review
    * 12.15 revise
    * 12.31 revise submit + with editor
    * 01.01 under editor assessment
    * 01.03 under review
    * 01.04 accept

    26

    展开26条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-04-03 ms1000001138385127 来自湖南省

    请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-02-13 ms7000001992773197 来自河南省

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。
    24.10.24submit
    24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)
    24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)
    24.12.23submit
    25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)
    25.2.9submit
    25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)
    25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)
    under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录
    再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2023-12-22 P拾荒者 来自浙江省

    歇菜了,分配到国人编辑了,看看这几天是不是就被拒了

    41

    展开41条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2024-10-14 ms1000001788822122 来自上海

    审稿速度:3.0 | 投稿命中率:25.0
    偏重的研究方向:中药
    经验分享:今年2月份投稿
    今天想给大家分享一下比较重要的几个问题:
    1.阳性对照,这个是编辑要求的
    2.动物实验至少2个浓度,伦理要求比较高
    3.编辑要求wb要求内参和目的条带同一张膜

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2261534, encodeId=c328226153412, content=审稿速度:3.0 | 投稿命中率:5.0<br>偏重的研究方向:中药药理<br>经验分享:这个期刊太坑我,我因此准备延毕,我是12月26投稿,后面送审了,1月16号,Revise,四个审稿人,有2个审稿人都是小问题,因为过年耽误,我回来补实验,3月10号返回去,3月30号被拒稿,看见审稿人都同意接受,编辑拒稿了,说因为不符合期刊收录范围,我请问编辑第一步没有看我文章吗?瞎耽误人,这个期刊太离谱,最后跟编辑发了argue,不理会了,无语死了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94cf9533098, createdName=ms8000001456519294, createdTime=Tue Apr 22 14:21:15 CST 2025, time=2025-04-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2254930, encodeId=933322549307e, content=偏重的研究方向:中药单体;单体<br>经验分享:有没有人遇到过印度编辑的经历,感觉怎样呢?我的文章在他手里,一直under editor assessment 状态。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61659631265, createdName=ms3000001245664520, createdTime=Thu Mar 06 21:06:55 CST 2025, time=2025-03-06, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2259934, encodeId=648e2259934c8, content=偏重的研究方向:代谢组学;中药复方;作用机制<br>经验分享:有没有稿件是一位巴基斯坦的编辑处理的,一直是under editor assessment。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Thu Apr 10 17:22:11 CST 2025, time=2025-04-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2260135, encodeId=fa5a2260135be, content=求助under editor assessment需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a22184874, createdName=雨念, createdTime=Sat Apr 12 12:47:31 CST 2025, time=2025-04-12, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2108776, encodeId=956b2108e7675, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:中药单体;药理机制<br>经验分享:终于轮到我来分享经验l!这次投稿意料之外的快,可能是方向比较符合编辑的胃口,只送了一次外审,修回后就接收了,整个投稿流程也非常顺利,具体时间如下:<br>* 11.08 submit<br>* 11.11 改格式<br>* 11.14 under editor assessment <br>* 11.15 reviewer invited + under review <br>* 12.15 revise<br>* 12.31 revise submit + with editor <br>* 01.01 under editor assessment <br>* 01.03 under review<br>* 01.04 accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59476423409, createdName=ms5000001894093922, createdTime=Wed Jan 04 15:01:02 CST 2023, time=2023-01-04, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2259027, encodeId=d6ba225902e7b, content=请问有朋友们知道论文word版手稿格式嘛,包括图片和表格怎么放,首行缩进啥的?官网一直找不到,谢谢朋友们!!!!2481359292*******, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e08c9436624, createdName=ms1000001138385127, createdTime=Thu Apr 03 21:55:18 CST 2025, time=2025-04-03, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2251762, encodeId=0eb22251e62df, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享:之前写的中文内容去投都很不顺利,这次特别感谢Phytomedicine杂志能收我的论文,在投稿的4个月里把这个期刊论坛都翻烂了,但是也真的给我很多帮助,我也分享一下我的投稿经验给大家做一些参考。<br>24.10.24submit<br>24.11.4under review(期间需要换一次编辑会发邮箱通知,开始外审也会发邮箱通知)<br>24.12.5revise(至少要有两个外审专家,只要进入外审可以关注爱思唯尔的公众号跟踪自己的文章看邀请了多少专家,多少专家接受等。大于两个专家审稿完成后会重新回到编辑手里DIP,我DIP大概15天)<br>24.12.23submit<br>25.2.5revise(编辑很快外审还是送到第一次给我们审稿的那两位专家,但是第二个审稿人一直没有接受邀请所以等了很久一直处于under invited状态,一个同意一个又提了两个小问题)<br>25.2.9submit<br>25.2.10under review(我下午提交的晚上到编辑手里,大概两个小时外审,就开始邀请还提了一个问题的审稿人审稿,第二天上午这个审稿人很快审完)<br>25.2.11accept(审稿人审完后大概半天左右就接受了,这个过程很快)<br>under review是有审稿人接受邀请开始审稿(具体人数不确定的)under invited正在邀请审稿人 accept的邮件只发导师邮箱 WB可以不提供全膜我提供了三次原始记录<br>再次感谢这个论坛给我很大帮助,谢谢审稿专家,谢谢Phytomedicine杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36669472996, createdName=ms7000001992773197, createdTime=Thu Feb 13 11:50:11 CST 2025, time=2025-02-13, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2176492, encodeId=18b221e64926e, content=歇菜了,分配到国人编辑了,看看这几天是不是就被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=41, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f132419863, createdName=P拾荒者, createdTime=Fri Dec 22 10:48:09 CST 2023, time=2023-12-22, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2230920, encodeId=0dfa22309202d, content=审稿速度:3.0 | 投稿命中率:25.0<br>偏重的研究方向:中药<br>经验分享:今年2月份投稿<br>今天想给大家分享一下比较重要的几个问题:<br>1.阳性对照,这个是编辑要求的<br>2.动物实验至少2个浓度,伦理要求比较高<br>3.编辑要求wb要求内参和目的条带同一张膜, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822122, createdTime=Mon Oct 14 23:06:26 CST 2024, time=2024-10-14, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2254496, encodeId=e73122544960d, content=那个author agreement 怎么打开啊 链接打不开 有大佬知道吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/6E31326AD2942CE3345818AF20B339B8/100, createdBy=fc022126093, createdName=kind, createdTime=Tue Mar 04 08:30:22 CST 2025, time=2025-03-04, status=1, ipAttribution=四川省)]
    2025-03-04 kind 来自四川省

    那个author agreement 怎么打开啊 链接打不开 有大佬知道吗

    2

    展开2条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分